Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CHRNA1 anticorps (AA 332-457)

CHRNA1 Reactivité: Souris, Rat WB, IF Hôte: Souris Monoclonal 26-Acetylcholine Receptor alpha unconjugated
N° du produit ABIN968298
  • Antigène Voir toutes CHRNA1 Anticorps
    CHRNA1 (Acetylcholine Receptor Subunit alpha (CHRNA1))
    Épitope
    • 9
    • 9
    • 8
    • 6
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 332-457
    Reactivité
    • 52
    • 49
    • 27
    • 7
    • 6
    • 5
    • 5
    • 4
    • 4
    • 3
    • 2
    • 2
    • 1
    Souris, Rat
    Hôte
    • 74
    • 2
    Souris
    Clonalité
    • 74
    • 2
    Monoclonal
    Conjugué
    • 32
    • 8
    • 7
    • 7
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    Cet anticorp CHRNA1 est non-conjugé
    Application
    • 36
    • 32
    • 16
    • 6
    • 6
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunofluorescence (IF)
     Réactivité croisée
    Souris
    Attributs du produit
    1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
    2. Please refer to us for technical protocols.
    3. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
    4. Source of all serum proteins is from USDA inspected abattoirs located in the United States.
    Purification
    The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.
    Immunogène
    Rat Acetylcholine Receptor alpha aa. 332-457
    Clone
    26-Acetylcholine Receptor alpha
    Isotype
    IgG2a
    Top Product
    Discover our top product CHRNA1 Anticorps primaire
  • Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    250 μg/mL
    Buffer
    Aqueous buffered solution containing BSA, glycerol, and ≤0.09 % sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Store undiluted at -20° C.
  • Kincer, Uittenbogaard, Dressman, Guerin, Febbraio, Guo, Smart: "Hypercholesterolemia promotes a CD36-dependent and endothelial nitric-oxide synthase-mediated vascular dysfunction." dans: The Journal of biological chemistry, Vol. 277, Issue 26, pp. 23525-33, (2002) (PubMed).

    Spencer, Guyon, Sorimachi, Potts, Richard, Herasse, Chamberlain, Dalkilic, Kunkel, Beckmann: "Stable expression of calpain 3 from a muscle transgene in vivo: immature muscle in transgenic mice suggests a role for calpain 3 in muscle maturation." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 99, Issue 13, pp. 8874-9, (2002) (PubMed).

    Garchon, Djabiri, Viard, Gajdos, Bach: "Involvement of human muscle acetylcholine receptor alpha-subunit gene (CHRNA) in susceptibility to myasthenia gravis." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 91, Issue 11, pp. 4668-72, (1994) (PubMed).

    Schröder, Reinhardt-Maelicke, Schrattenholz, McLane, Kretschmer, Conti-Tronconi, Maelicke: "Monoclonal antibodies FK1 and WF6 define two neighboring ligand binding sites on Torpedo acetylcholine receptor alpha-polypeptide." dans: The Journal of biological chemistry, Vol. 269, Issue 14, pp. 10407-16, (1994) (PubMed).

    Tsim, Greenberg, Rimer, Randall, Salpeter: "Transcripts for the acetylcholine receptor and acetylcholine esterase show distribution differences in cultured chick muscle cells." dans: The Journal of cell biology, Vol. 118, Issue 5, pp. 1201-12, (1992) (PubMed).

  • Antigène
    CHRNA1 (Acetylcholine Receptor Subunit alpha (CHRNA1))
    Autre désignation
    Acetylcholine Receptor alpha (CHRNA1 Produits)
    Synonymes
    anticorps CHRNA1, anticorps ACHRA, anticorps ACHRD, anticorps CHRNA, anticorps CMS2A, anticorps FCCMS, anticorps SCCMS, anticorps NACHRA1, anticorps AI385656, anticorps AI608266, anticorps Achr-1, anticorps Acra, anticorps cholinergic receptor nicotinic alpha 1 subunit, anticorps cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle), anticorps CHRNA1, anticorps Chrna1
    Sujet
    Acetylcholine is an amine neurotransmitter at the neuromuscular junction. It is released from the presynaptic membrane of a cholinergic synapse into the synaptic cleft. It diffuses across the cleft and binds acetylcholine receptors (AChR) on the postsynaptic membrane. Receptor binding induces postsynaptic membrane depolarization and the generation of an action potential that produces effects such as muscle contraction. The AChR is a 250kDa pentameric complex of four transmembrane subunits in a stoichiometry of alpha2betagammadelta. In response to ligand binding, all subunits participate in the formation of an integral cation channel. However, the acetylcholine binding site is primarily within the alpha subunit. Myasthenia gravis (MG) is an autoimmune condition in which AchR levels are decreased. Autoantibodies bind and crosslink the AchRs leading to their internalization and degradation. This results in a decreased number of functional AChRs. Patients develop muscular weakness and some voluntary muscle fatigue. However, development of MG is also affected by genetic factors. One of the allelic forms of the AChRalpha gene appears to significantly contribute to MG susceptibility.
    Poids moléculaire
    49 kDa
    Pathways
    Skeletal Muscle Fiber Development
Vous êtes ici:
Support technique